References
< Back

CHARACTERIZE CANCER

Unlock novel epigenomic biomarkers to develop more targeted, personalized treatments.1-4

Epigenomics can enable more targeted, personalized treatment strategies, providing critical insights into tumor heterogeneity,
disease progression, and treatment response

Studies have shown novel epigenomic biomarkers can reveal:

Guardant Infinity is for research use only. Not for diagnostic purposes.

Adverse event prediction5

Enhanced patient identification6

Molecular tumor subtype identification6



Therapy response prediction7,8

See our latest posters on novel epigenomic biomarkers.

BioPharma Home